Abbott Laboratories/ US0028241000 /
30/08/2024 22:10:00 | Chg. +0.51 | Volume | Bid02:00:00 | Ask02:00:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
113.27USD | +0.45% | 4.32 mill. Turnover: 330.57 mill. |
113.35Bid Size: 700 | 113.50Ask Size: 200 | 197.08 bill.USD | 1.84% | 34.53 |
Assets
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 7,607 | 7,563 | 8,038 | 9,029 | 8,959 | ||||||
Intangible Assets | 21,473 | 18,942 | 17,025 | 14,784 | 12,739 | ||||||
Long-Term Investments | 883 | 897 | 883 | 821 | 816 | ||||||
Fixed Assets | 56,103 | 52,541 | 52,220 | 52,107 | 50,957 | ||||||
Inventories | 3,601 | 3,796 | 4,316 | 5,012 | 5,157 | ||||||
Accounts Receivable | 5,249 | 5,182 | 5,425 | 6,414 | 6,487 | ||||||
Cash and Cash Equivalents | 9,407 | 3,844 | 3,860 | 6,838 | 9,799 | ||||||
Current Assets | 20,147 | 14,632 | 15,667 | 20,441 | 24,239 | ||||||
Total Assets | 76,250 | 67,173 | 67,887 | 72,548 | 75,196 |
Liabilities
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 2,402 | 2,975 | 3,252 | 3,946 | 4,408 | ||||||
Long-term debt | 27,210 | 19,359 | 16,661 | 18,527 | 17,296 | ||||||
Liabilities to Banks | 206 | 200 | 201 | 213 | 0.0000 | ||||||
Provisions | 309 | 305 | 226 | 362 | 306 | ||||||
Liabilities | 45,152 | 36,451 | 36,586 | 39,545 | 39,172 | ||||||
Share Capital | 23,206 | 23,512 | 23,853 | 24,145 | 24,470 | ||||||
Total Equity | 31,098 | 30,722 | 31,301 | 33,003 | 36,024 | ||||||
Minority Interests | 201 | 198 | 213 | 219 | 222 | ||||||
Total liabilities equity | 76,250 | 67,173 | 67,887 | 72,548 | 75,196 |
Income Statement
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 27,390 | 30,578 | 31,904 | 34,608 | 43,075 | ||||||
Depreciation (total) | 3,021 | 3,278 | 3,014 | 3,327 | 3,538 | ||||||
Operating Result | 1,726 | 3,650 | 4,532 | 5,357 | 8,425 | ||||||
Interest Income | -780 | -721 | -576 | -500 | -490 | ||||||
Income Before Taxes | 2,231 | 2,873 | 4,077 | 4,968 | 8,211 | ||||||
Income Taxes | 1,878 | 539 | 390 | 497 | 1,140 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 477 | 2,368 | 3,687 | 4,495 | 7,071 |
Per Share
Cash Flow
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 5,570 | 6,300 | 6,136 | 7,901 | 10,533 | ||||||
Cash Flow from Investing Activities | -9,618 | -1,356 | -1,815 | -2,215 | -2,008 | ||||||
Cash Flow from Financing | -5,281 | -10,391 | -4,289 | -2,779 | -5,494 | ||||||
Decrease / Increase in Cash | -9,213 | -5,563 | 16 | 2,978 | 2,961 | ||||||
Employees | 99,000 | 103,000 | 107,000 | 109,000 | 113,000 |